The experiment outlasted grants, moved between countries, and passed through several laboratories before anyone could write it up. In 2009, cynomolgus macaques were inoculated with material from cervids confirmed to have chronic wasting disease: elk, mule deer and white-tailed deer from different regions of the United States and Canada. Some animals received the material by mouth. Some received it into the brain by injection. Some received it on implanted steel wire, a method that concentrates prions at a single point. Then everyone waited. On 27 May 2026, Samia Hannaoui, Hermann Schaetzl and colleagues at the University of Calgary, with collaborators in Germany, the United States and the Canadian Food Inspection Agency, published the result in Science Advances. It is an animal study, and every sentence that follows describes animals.
The paper reports seven inoculated macaques plus non-inoculated controls, analysed up to 7.5 years after exposure, in a design where euthanasia was scheduled in advance and most animals were taken between five and ten years post-inoculation. Most stayed clinically well. Two did not look entirely well: AU501, exposed by mouth, and AU389, exposed by steel wire, showed wasting, ataxia, tremor and anxiety. The authors are careful about this, and so should we be: wasting appeared in five animals, and in three of those it was possibly linked to diabetes, which is common in female cynomolgus macaques of Mauritian origin. Tremor and anxiety are not a diagnosis. More striking was what the standard tests said, which was nothing. Immunoblotting after proteinase K digestion found no protease-resistant prion protein in the central nervous system, by either route. Histology and immunohistochemistry were inconclusive. Only the very sensitive amplification assays, PMCA and RT-QuIC, picked up low-level seeding activity, in brain, spinal cord and spleen, including in tissues distant from where the inoculum went in.
The part that has travelled fastest is the rodent bioassay, and it is the part most often described wrongly. The first passage out of macaque tissue went into TgElk mice, which overexpress elk prion protein, not human prion protein. Those mice developed prion disease at low attack rates, up to 20 percent, or one mouse in five, with incubation periods from 94 to 344 days and signs including ataxia, rigid tail, kyphosis and weight swings, and again without detectable protease-resistant prion protein. It was the next step that produced the arresting number. Brain, spinal cord and spleen material from those mice was passaged into bank voles carrying the 109 methionine allele, the less susceptible of the two vole variants; voles given spinal cord from one adapted mouse developed clinical prion disease with a 100 percent attack rate and average survival of about 464 days, and onward passage of vole brain into mice overexpressing deer prion protein again reached 100 percent. Prions from gastrointestinal tissue transmitted to voles too. Something biologically real was being carried by animals that a routine post-mortem would have called clean.
That is the finding. Now the fence around it. A cervidized mouse is a detector for deer prions, not a stand-in for a person, and the bank vole is the most promiscuous host in prion biology: work published in PLOS Pathogens in 2013 established it as the shortest-incubation model available, taking CWD from elk, mule deer and white-tailed deer with 100 percent attack rates. A 100 percent figure in voles measures the vole, not the human species barrier. The group's separate 2022 study in Acta Neuropathologica, in mice engineered to overexpress human prion protein, is the humanized arm of this story, and it belongs in a different paragraph from this one. Nor is contamination fully off the table: intracerebral and wire inoculation leave residual material behind, and the authors' argument is that seeding turned up in tissues downstream of the inoculation site, which they say is difficult to reconcile with residual inoculum, "while not excluding alternative explanations". Their abstract offers the reading as one interpretation, not a conclusion.
It also lands in a literature that pushes the other way. In 2018, in the Journal of Virology, Brent Race and colleagues at the NIH reported seven CWD-inoculated cynomolgus macaques euthanized 11 to 13 years after exposure with no clinical, pathological or biochemical evidence of transmission. In 2024, in Emerging Infectious Diseases, an NIH group exposed human cerebral organoids to high concentrations of CWD from three sources and saw no propagation over 180 days, which they read as support for a strong species barrier. And the epidemiology has not moved: no human case of prion disease has been confirmed to have been caused by chronic wasting disease.
So what changes for a family reading this? Clinically, nothing today. If someone in your house is living with Creutzfeldt-Jakob disease or another prion disease, this paper does not reclassify that diagnosis, does not identify a cause, and does not point to a treatment. Where it bites is on two quieter questions that belong to laboratories and public health agencies rather than to any individual: whether a host can carry transmissible prions for years while looking and testing normal, and whether the tests used as reassurance are sensitive enough to say so. Silent infection and zoonosis are separate claims, and this study advances the first while leaving the second exactly where it was.